Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics' Fourth Quarter and Full Year 2024 Results Conference Call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.50 | 4,000 | $5,996.00 | 15,188 | 2024-09-13 | Filing | |
$1.35 | 6,285 | $8,511.78 | 11,188 | 2024-09-12 | Filing | |
$1.35 | 12,500 | $16,875.00 | 48,921 | 2024-09-11 | Filing | |
$1.34 | 5,000 | $6,681.00 | 26,497 | 2024-09-11 | Filing | |
$1.23 | 8,000 | $9,839.20 | 20,425 | 2024-09-10 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.96 | 2,068 | $4,052.66 | 170 | 2023-11-20 | Filing | |
$0.31 | 1,500 | $472.05 | 8,500 | 2022-12-30 | Filing | |
$0.34 | 473,831 | $161,007.77 | 4,543,086 | 2018-02-14 | Filing | |
$0.31 | 101,710 | $31,652.15 | 5,016,917 | 2018-02-13 | Filing | |
$0.31 | 185,272 | $58,323.63 | 5,118,627 | 2018-02-12 | Filing |